Document is current

Article History

Accepted: 12 September 2024

First Online: 15 October 2024

Declarations

:

: All authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article. Conceptualization: all authors contributed equally; writing: all authors contributed equally. All authors have given their approval for this version to be published and agree to be accountable for all aspects of the work as a whole.

: The data that support the findings of the original study () will be available in the Vivli repository () as long as conditions of data disclosure specified in the policy section of the Vivli website are satisfied. Individual participant data (text, tables, figures, and appendices) that provide the basis for the results reported in this paper will be deidentified and shared.

: Not applicable.

: Not applicable.

: This study was sponsored by Kyowa Kirin Co., Ltd.

: M.M. reports grants from Kyowa Kirin during the conduct of the study as well as grants and/or personal fees from AbbVie, Amgen Inc., ARISTEA Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eisai, Eli Lilly, Janssen Pharma, Kyowa Kirin, Maruho, Novartis Pharma, Taiho Pharmaceutical, and Torii Pharmaceutical outside the submitted work. Y.O. reports grants from Kyowa Kirin during the conduct of the study as well as grants and/or personal fees from AbbVie, Amgen Inc., Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eisai, Eli Lilly, Janssen Pharma, Jimro, Kyowa Kirin, LEO Pharma, Maruho, Mitsubishi Tanabe Pharma, Novartis, Pfizer, Sanofi, Shiseido, Sun Pharma, Taiho Pharmaceutical, Torii Pharmaceutical, and UCB Pharma outside the submitted work. S.K. reports grants from Kyowa Kirin during the conduct of the study as well as personal fees from AbbVie, Janssen Pharma, and Taiho Pharmaceutical outside the submitted work. SS reports grants from Kyowa Kirin during the conduct of the study as well as grants and/or personal fees from AbbVie, Amgen Inc., Eisai, Eli Lilly, Janssen Pharma, Kaken Pharmaceutical, Kyowa Kirin, Maruho, Mitsubishi Tanabe Pharma, Nippon Kayaku, Nippon Zoki Pharmaceutical, Sanofi, Sun Pharma, Taiho Pharmaceutical, Torii Pharmaceutical, and UCB Pharma outside the submitted work. N.K. and Y. Ouchi are employees of Kyowa Kirin. T.T. reports personal fees from Kyowa Kirin during the conduct of the study as well as grants and/or personal fees from AbbVie, Amgen Inc., Boehringer Ingelheim, Maruho, and Taiho Pharmaceutical outside the submitted work.